ES2063739T3 - Dna humano en el diagnostico de retinoblastoma. - Google Patents

Dna humano en el diagnostico de retinoblastoma.

Info

Publication number
ES2063739T3
ES2063739T3 ES87307095T ES87307095T ES2063739T3 ES 2063739 T3 ES2063739 T3 ES 2063739T3 ES 87307095 T ES87307095 T ES 87307095T ES 87307095 T ES87307095 T ES 87307095T ES 2063739 T3 ES2063739 T3 ES 2063739T3
Authority
ES
Spain
Prior art keywords
retinoblastoma
diagnosis
human dna
dna
alleles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES87307095T
Other languages
English (en)
Inventor
Thaddeus P Dryja
Stephen Friend
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Whitehead Institute for Biomedical Research
Massachusetts Eye and Ear
Original Assignee
Massachusetts Eye and Ear Infirmary
Whitehead Institute for Biomedical Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Massachusetts Eye and Ear Infirmary, Whitehead Institute for Biomedical Research filed Critical Massachusetts Eye and Ear Infirmary
Application granted granted Critical
Publication of ES2063739T3 publication Critical patent/ES2063739T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4736—Retinoblastoma protein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pathology (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Toxicology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Hospice & Palliative Care (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

EL MATERIAL GENETICO CORRESPONDIENTE A UN RETINOBLASTOMA HUMANO NORMAL ES COMPARADO CON EL ADN DE UN PACIENTE PARA DIAGNOSTICAR LA PRESENCIA DE ALELOS DE RETINOBLASTOMA DEFECTIVOS.
ES87307095T 1986-08-11 1987-08-11 Dna humano en el diagnostico de retinoblastoma. Expired - Lifetime ES2063739T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US89516386A 1986-08-11 1986-08-11

Publications (1)

Publication Number Publication Date
ES2063739T3 true ES2063739T3 (es) 1995-01-16

Family

ID=25404097

Family Applications (2)

Application Number Title Priority Date Filing Date
ES87307095T Expired - Lifetime ES2063739T3 (es) 1986-08-11 1987-08-11 Dna humano en el diagnostico de retinoblastoma.
ES94103625T Expired - Lifetime ES2189795T3 (es) 1986-08-11 1987-08-11 Adn humano para la diagnosis de retinoblastoma.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES94103625T Expired - Lifetime ES2189795T3 (es) 1986-08-11 1987-08-11 Adn humano para la diagnosis de retinoblastoma.

Country Status (7)

Country Link
EP (2) EP0259031B1 (es)
JP (4) JP2779161B2 (es)
AT (2) ATE230442T1 (es)
AU (1) AU600293B2 (es)
CA (1) CA1341576C (es)
DE (2) DE3750738T2 (es)
ES (2) ES2063739T3 (es)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8712646D0 (en) * 1987-05-29 1987-07-01 Clayton Found Res Structural evidence
US5851991A (en) * 1987-08-31 1998-12-22 The Regents Of The University Of California Therapeutic use of the retinoblastoma susceptibility gene product
US7105156B1 (en) 1987-09-17 2006-09-12 The Regents Of The University Of California Method of using an adenoviral vector encoding a retinoblastoma protein to treat hyperproliferating cells
EP0398955B1 (en) * 1988-01-21 1998-07-08 MASSACHUSETTS EYE & EAR INFIRMARY Diagnosis of retinoblastoma
ATE108491T1 (de) * 1988-03-18 1994-07-15 Baylor College Medicine Mutationsnachweis durch kompetitiven oligonukleotid-priming.
JP2706667B2 (ja) * 1988-10-06 1998-01-28 株式会社セラリカ野田 抗 体
EP0390323B2 (en) * 1989-03-29 2012-08-08 Johns Hopkins University Detection of loss of the wild-type p53 gene
CA2014473A1 (en) * 1989-04-14 1990-10-14 Hong-Ji Xu Purified, highly specific antibodies against gene products including retinoblastoma and method
US5262321A (en) * 1991-05-31 1993-11-16 Dana-Farber Cancer Institute DNA encoding p107 tumor suppressor
TW346397B (en) * 1991-10-17 1998-12-01 Univ California Cell cycle controlling compositions and methods of using same
EP0675967A4 (en) * 1992-10-01 1999-04-28 Gen Hospital Corp FUNCTIONAL METHOD FOR DETERMINING TUMOR SUPPRESSOR GENES.
JPH06296489A (ja) * 1992-11-20 1994-10-25 Univ Texas Syst 網膜芽腫−関連タンパク質をコードする細胞性遺伝子
US5496731A (en) * 1993-03-25 1996-03-05 Xu; Hong-Ji Broad-spectrum tumor suppressor genes, gene products and methods for tumor suppressor gene therapy
AU7834994A (en) * 1993-09-13 1995-04-03 Canji, Inc. Therapeutic use of the retinoblastoma susceptibility gene product
US5550020A (en) * 1994-07-08 1996-08-27 Visible Genetics Inc. Method, reagents and kit for diagnosis and targeted screening for retinoblastoma
US6974666B1 (en) * 1994-10-21 2005-12-13 Appymetric, Inc. Methods of enzymatic discrimination enhancement and surface-bound double-stranded DNA
US5753439A (en) * 1995-05-19 1998-05-19 Trustees Of Boston University Nucleic acid detection methods
US5670325A (en) * 1996-08-14 1997-09-23 Exact Laboratories, Inc. Method for the detection of clonal populations of transformed cells in a genomically heterogeneous cellular sample
US5741650A (en) * 1996-01-30 1998-04-21 Exact Laboratories, Inc. Methods for detecting colon cancer from stool samples
US6146828A (en) * 1996-08-14 2000-11-14 Exact Laboratories, Inc. Methods for detecting differences in RNA expression levels and uses therefor
US6203993B1 (en) 1996-08-14 2001-03-20 Exact Science Corp. Methods for the detection of nucleic acids
US5928870A (en) * 1997-06-16 1999-07-27 Exact Laboratories, Inc. Methods for the detection of loss of heterozygosity
US6020137A (en) * 1996-08-14 2000-02-01 Exact Laboratories, Inc. Methods for the detection of loss of heterozygosity
US5952178A (en) * 1996-08-14 1999-09-14 Exact Laboratories Methods for disease diagnosis from stool samples
US6300077B1 (en) 1996-08-14 2001-10-09 Exact Sciences Corporation Methods for the detection of nucleic acids
US6100029A (en) * 1996-08-14 2000-08-08 Exact Laboratories, Inc. Methods for the detection of chromosomal aberrations
US5830665A (en) * 1997-03-03 1998-11-03 Exact Laboratories, Inc. Contiguous genomic sequence scanning
US6268136B1 (en) 1997-06-16 2001-07-31 Exact Science Corporation Methods for stool sample preparation
US6406857B1 (en) 1997-06-16 2002-06-18 Exact Sciences Corporation Methods for stool sample preparation
US6503718B2 (en) 1999-01-10 2003-01-07 Exact Sciences Corporation Methods for detecting mutations using primer extension for detecting disease
US6280947B1 (en) 1999-08-11 2001-08-28 Exact Sciences Corporation Methods for detecting nucleotide insertion or deletion using primer extension
WO2000050640A1 (en) 1999-02-25 2000-08-31 Exact Laboratories, Inc. Methods for preserving dna integrity
US6586177B1 (en) 1999-09-08 2003-07-01 Exact Sciences Corporation Methods for disease detection
AU4714201A (en) 1999-12-07 2001-06-18 Exact Sciences Corporation Supracolonic aerodigestive neoplasm detection
US6428964B1 (en) 2001-03-15 2002-08-06 Exact Sciences Corporation Method for alteration detection
AU2003213107A1 (en) 2002-02-15 2003-09-09 Exact Sciences Corporation Methods for analysis of molecular events
US7981607B2 (en) 2004-08-27 2011-07-19 Esoterix Genetic Laboratories LLC Method for detecting recombinant event
US9109256B2 (en) 2004-10-27 2015-08-18 Esoterix Genetic Laboratories, Llc Method for monitoring disease progression or recurrence
WO2007044071A2 (en) 2005-04-21 2007-04-19 Exact Sciences Corporation Analysis of heterogeneous nucleic acid samples
JP4928311B2 (ja) * 2006-12-11 2012-05-09 本田技研工業株式会社 車両のドア及びその製造方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4535058A (en) * 1982-10-01 1985-08-13 Massachusetts Institute Of Technology Characterization of oncogenes and assays based thereon
US4599305A (en) * 1984-07-16 1986-07-08 The Regents Of The University Of California Method and composition for detection of human chronic myelogenous leukemia
GB8712646D0 (en) * 1987-05-29 1987-07-01 Clayton Found Res Structural evidence

Also Published As

Publication number Publication date
DE3750738T2 (de) 1995-06-01
JPH10337190A (ja) 1998-12-22
EP0608004B1 (en) 2003-01-02
JPS63119698A (ja) 1988-05-24
JP3051894B2 (ja) 2000-06-12
DE3752360T2 (de) 2004-02-12
CA1341576C (en) 2008-07-08
DE3750738D1 (de) 1994-12-15
EP0259031A3 (en) 1990-09-12
JPH10319013A (ja) 1998-12-04
EP0608004A3 (en) 1994-08-10
ES2189795T3 (es) 2003-07-16
JP2902362B2 (ja) 1999-06-07
EP0259031A2 (en) 1988-03-09
JP3110372B2 (ja) 2000-11-20
JP2779161B2 (ja) 1998-07-23
AU7676287A (en) 1988-05-19
ATE230442T1 (de) 2003-01-15
EP0608004A2 (en) 1994-07-27
EP0259031B1 (en) 1994-11-09
DE3752360D1 (de) 2003-02-06
JPH09121898A (ja) 1997-05-13
AU600293B2 (en) 1990-08-09
ATE113993T1 (de) 1994-11-15

Similar Documents

Publication Publication Date Title
ES2063739T3 (es) Dna humano en el diagnostico de retinoblastoma.
IT1206279B (it) Sensore diagnostico monitorizzato
DK8987A (da) Lysstraaleklaede for medicinsk behandling
FI910958A0 (fi) Manuell in situ- -hybridisationsbestaemning.
NO885456D0 (no) Diagnostisk elektrode.
KR880001276A (ko) 보육기
DE3668704D1 (de) Fluoreszierende verbindungen und ihr biologischer diagnostischer zweck.
DE3783966T2 (de) Reagens zur pruefung von periodentalen erkrankungen.
DK133787D0 (da) Dobbelt displaymonitor
NO880274D0 (no) Medisinsk diagnoseanordning.
DE3786077T2 (de) Ultraschalldiagnose-anordnung.
FR2597995B1 (fr) Dispositif d'eveil programmable en fonction du rythme biologique personnel
BR8807618A (pt) Composicoes de poliisocinato contendo polimeros ou compostos rigidos e poliuretanas preparadas a partir das mesmas
DE3786210D1 (de) Herzschrittmacher mit sauerstoffsensor.
DK155487A (da) Patientlifte
DE3888684D1 (de) Behandlung und diagnose von klauenseuche unter verwendung der basischen protease von bacteroides nodosus.
FI861093A0 (fi) Bioelektrisk patientmonitor.
ATE106745T1 (de) Verwendung von 6rf zur diagnose von m. alzheimer.
NO169978C (no) Biologisk diagnoseanordning
DE3650559D1 (de) Kautschukähnliches akrylpolymer, latex und herstellung
RO94179A2 (ro) Metoda de diagnostic utilizind termografia computerizata de contact
ATE50065T1 (de) Fluoreszierende verbindungen und ihr biologischer diagnostischer zweck.
BR8601494A (pt) Estimulador nervo-facial clinico
DK517287A (da) Proevebehandlingsenhed
NO890265L (no) Biologisk diagnostisk analysesystem.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 259031

Country of ref document: ES